Physician profile
Rori L Bridges
NPI 1114170529
$891.78
in general payments reported to CMS, 2019-2025
20 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $281 · 2022: $262 · 2023: $115 · 2024: $53.78 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $100.48 | 2022-2023 | Verquvo |
| Lilly USA, LLC | $98.31 | 2021-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $87.94 | 2021-2023 | Farxiga |
| Abbvie INC. | $85.98 | 2021-2022 | |
| Novo Nordisk INC | $73.63 | 2021-2023 | Rybelsus, Ozempic |
| Sumitomo Pharma America, INC. | $60.40 | 2024-2025 | Gemtesa, Myfembree |
| Janssen Pharmaceuticals, INC | $57.25 | 2021-2022 | |
| Astellas Pharma US INC | $49.66 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $43.13 | 2024-2025 | |
| Abbott Laboratories | $39.05 | 2022-2023 | Freestyle Libre 2 |
| Pfizer INC. | $36.78 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $34.60 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.40 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.74 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.53 | 2025 | Trintellix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.42 | 2025 | |
| Idorsia Pharmaceuticals US INC | $15.27 | 2023 | Quviviq |
| Inari Medical, INC. | $14.17 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Glaxosmithkline, LLC. | $12.50 | 2022 | |
| Organon LLC | $5.54 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rori Bridges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.